Back to Search
Start Over
Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer.
- Source :
-
International Journal of Molecular Sciences . May2023, Vol. 24 Issue 10, p8722. 12p. - Publication Year :
- 2023
-
Abstract
- The efficacy of current immunotherapies remains limited in many solid epithelial malignancies. Recent investigations into the biology of butyrophilin (BTN) and butyrophilin-like (BTNL) molecules, however, suggest these molecules are potent immunosuppressors of antigen-specific protective T cell activity in tumor beds. BTN and BTNL molecules also associate with each other dynamically on cellular surfaces in specific contexts, which modulates their biology. At least in the case of BTN3A1, this dynamism drives the immunosuppression of αβ T cells or the activation of Vγ9Vδ2 T cells. Clearly, there is much to learn regarding the biology of BTN and BTNL molecules in the context of cancer, where they may represent intriguing immunotherapeutic targets that could potentially synergize with the current class of immune modulators in cancer. Here, we discuss our current understanding of BTN and BTNL biology, with a particular focus on BTN3A1, and potential therapeutic implications for cancer. [ABSTRACT FROM AUTHOR]
- Subjects :
- *T cells
*CANCER cells
*IMMUNOMODULATORS
*BIOLOGY
Subjects
Details
- Language :
- English
- ISSN :
- 16616596
- Volume :
- 24
- Issue :
- 10
- Database :
- Academic Search Index
- Journal :
- International Journal of Molecular Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 163966387
- Full Text :
- https://doi.org/10.3390/ijms24108722